Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    The CLL Sessions: frontline therapy, BTK inhibitors, MRD negativity & novel therapies

    The CLL Sessions: frontline therapy, BTK inhibitors, MRD negativity & novel therapies

    FromVJHemOnc Podcast

    Start listeningView podcast show

    The CLL Sessions: frontline therapy, BTK inhibitors, MRD negativity & novel therapies

    FromVJHemOnc Podcast

    ratings:
    Length:
    44 minutes
    Released:
    Jul 31, 2020
    Format:
    Podcast episode

    Description

    A remarkable increase in the understanding of the pathogenesis of chronic lymphocytic leukemia (CLL) has led to the development of...
    The post The CLL Sessions: frontline therapy, BTK inhibitors, MRD negativity & novel therapies appeared first on VJHemOnc.
    Released:
    Jul 31, 2020
    Format:
    Podcast episode

    Titles in the series (100)

    The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com